Robin Cook Redux, in The Economist

The Bridge is in good company this week, in bouncing off Robin Cook’s medical thriller “Foreign Body.” The Economist led off its own lengthy feature about medical tourism with a reference to the novel, also.

… Central to the plot is the story of Maria Hernandez, a working-class American woman who travels to Delhi to get a hip replacement she could not afford back home. Alas, she and other medical tourists die in mysterious circumstances. Contrast Ms Hernandez’s fate with that of another American health tourist, Robin Steele. Mr Steele, a real patient, recently went to India’s Wockhardt hospital chain for a heart operation. Not only is he in fine shape, but he also enjoyed a holiday afterwards and saved several thousand dollars to boot.

Mrs. Hernandez’s tragedy may sell books, but Mr Steele’s good health is more typical. The future of health care, long one of the most local of all businesses, promises to be increasingly global.

Boldface is added for emphasis. The Economist claims “… to take part in a severe contest between intelligence, which presses forward, and an unworthy, timid ignorance obstructing our progress.” Apparently, for the 164-year-old journal, medical tourism is, well, just plain smart.

The article generally covers ground that we have covered here on The Bridge, stressing the potential of medical travel without succumbing to hype.

… Paul Mango, the chief author of a report by McKinsey, a management consultancy, disputes wild-eyed claims that millions of patients are already travelling abroad. Yet even he predicts that the future for medical travel is bright, and that in the long run it may even “largely dispel the idea that health care is a purely local service.”

Regina Herzlinger, of Harvard Business School, broadly agrees: “The medical travel market is a bit over-hyped today, but economics dictates why it will become huge over time: if a supplier has very high prices and erratic quality, it creates an opening for nimbler rivals.” That supplier is America’s health-care system, a $2.4 trillion colossus in desperate need of reform.

We discuss a companion editorial piece in The Economist here.